Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 79,714 | $14.00 | $1.12MSell |
Paul Bolno | President and CEO | 2024-10-16 | 90,474 | $15.00 | $1.36MSell |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 22,500 | $13.50 | $303.75kSell |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 22,500 | $2.83 | $63.68kBuy |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 65,625 | $13.75 | $902.34kSell |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 65,625 | $3.14 | $206.06kBuy |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 40,997 | $13.00 | $532.96kSell |
Chris Francis | SVP Corporate Development Head of Emerging Areas | 2024-10-16 | 40,997 | $2.48 | $101.67kBuy |
Kyle Moran | Chief Financial Officer | 2024-10-11 | 25,000 | $2.48 | $62.00kBuy |
Gsk PLC | 10% Owner | 2024-09-27 | 2,791,930 | $8.00 | $22.34MBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Gsk PLC | 22.01% | 27,459,452 | $379.76M | Insider |
Ra Capital Management LP | 20.66% | 25,775,622 | $356.48M | Insider |
Ra Capital Management LP | 14.59% | 18,202,009 | $251.73M | Institution |
Ken Takanashi | 6.18% | 7,705,305 | $106.56M | Insider |
Maverick Capital Ltd | 6.15% | 7,669,361 | $106.07M | Institution |
Blackrock Inc | 5.40% | 6,738,735 | $93.20M | Institution |
M28 Capital Management LP | 4.94% | 6,164,548 | $85.26M | Institution |
Adage Capital Partners GP LLC | 4.30% | 5,357,719 | $74.10M | Institution |
683 Capital Management LLC | 4.27% | 5,325,000 | $73.64M | Institution |
Artal Group Sa | 3.66% | 4,566,251 | $63.15M | Institution |